Briefcase

Crafting an Individualized Plan to Optimize Patient Outcomes: Safe, Effective, and Personalized Treatment

Launch Date
05/09/2022
Credit Amount
1.00 Hours
Credit Expires
05/09/2023

Faculty

Richard K. Bogan, MD, FCCP, FAASM
Associate Clinical Professor
University of South Carolina Medical School, Columbia, SC
Medical University of South Carolina, Charleston, SC
Principal, Bogan Sleep Consultants, LLC
Columbia, SC
Richard K. Bogan, MD, FCCP, FAASM

Dr. Bogan is the President of Bogan Sleep Consultants, LLC. He is also Associate Clinical Professor at the University of South Carolina School of Medicine and Associate Clinical Professor at the Medical University of South Carolina in Charleston, S.C.

Dr. Bogan received his bachelor’s degree in chemistry from Wofford College and his MD degree from the Medical University of South Carolina in Charleston. He served his internship and residency, as well as Chief Medical Resident, at the University of Alabama Hospital and Clinics in Birmingham. Thereafter, he completed a fellowship and assistant professorship in the Pulmonary Division of the Department of Medicine at the University of Alabama School of Medicine. He has been certified by the American boards of Sleep Medicine, Internal Medicine and Pulmonary Diseases.

Dr. Bogan has served as principal investigator on numerous clinical trials in the past and continues to do so now. He has a variety of publications and research interests that focus on topics such as narcolepsy, insomnia, sleep apnea, shift work sleep disorder, restless legs syndrome/periodic limb movement disorder, chronic fatigue/fibromyalgia and circadian rhythm abnormality.

Paula K. Schweitzer, PhD
Director of Research Sleep Medicine and Research Center St. Luke's Hospital Chesterfield, MO
Paula K. Schweitzer, PhD

Paula K. Schweitzer is Director of Research at the Sleep Medicine and Research Center at St. Luke’s Hospital in St. Louis. She received her doctorate in experimental psychology from Saint Louis University and did postgraduate work in sleep medicine at The Milton S. Hershey Medical Center (Pennsylvania State School of Medicine) in Hershey, PA. She is certified by the American Board of Sleep Medicine as a Ph.D. specializing in Clinical Sleep Disorders. She has authored over one hundred scientific manuscripts and book chapters. She has been principal- or co-investigator for more than 90 research studies. Her primary research interests include clinical pharmacology, sleep apnea, insomnia, and the relationship of sleep and behavior.

Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Additional Formats

Statement of Need

Excessive daytime sleepiness (EDS) is a cardinal feature of obstructive sleep apnea (OSA). It confers significant disability, including compromised safety when driving or at work, impairments in work/academic performance and personal/family relationships, as well as increased prevalence of psychiatric and medical comorbidities. Treatment planning in patients with OSA-related EDS is highly specialized, considering the psychiatric and medical comorbidities that can complicate treatment decisions. Successfully treating persistent OSA-related EDS has been shown to improve medical comorbidities such as hypertension and diabetes. However, developing personalized treatment strategies to optimally manage complex patients often poses significant challenges to clinicians.

Join Drs. Richard Bogan and Paula Schweitzer as they discuss case 2 of this 3-part CMEO BriefCase series and provide guidance on the nuances of personalizing treatment selection and strategies to monitor treatment effectiveness to provide safe, effective, long-term care.

 

Learning Objectives

At the end of this CME/CE activity, participants should be able to position treatment strategies for OSA-related EDS based on individual patients’ profiles.

Financial Support

This program is supported by an independent medical education grant from Jazz Pharmaceuticals.

Target Audience

Physicians, PAs, nurse practitioners, nurses, and pharmacists specializing in sleep, pulmonology, psychiatry, neurology and/or primary care.

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians (ACCME) 1.0

CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. CME Outfitters, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 1.0

This activity is designated for 1.0 contact hour.

Note for California Nurses

This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters LLC’s provider number is CEP15510.

Pharmacists/Pharmacy Tech (ACPE) 1.0

This application-based activity is approved for 1.0 contact hour (0.10 CEUs) of continuing pharmacy credit.

PAs (AAPA) 1.0

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until the expiration date listed above. PAs should only claim credit commensurate with the extent of their participation.

ABIM MOC

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity

This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Bogan reports the following financial relationships: Consultant: Harmony Biosciences, LLC; Jazz Pharmaceuticals, Inc.; and Takeda Pharmaceuticals U.S.A., Inc. Grants: Axsome Therapeutics, Inc.; Eisai Inc.; Flamel Technologies; Fresca Medical, Inc.; Harmony Biosciences, LLC; Idorsia Pharmaceuticals; Jazz Pharmaceuticals, Inc.; Merck & Co., Inc.; Philips; Suven Life Sciences; and Takeda Pharmaceuticals U.S.A., Inc. Speakers Bureau: Eisai Inc.; Harmony Biosciences, LLC; and Jazz Pharmaceuticals, Inc.

Dr. Schweitzer reports the following financial relationships: Advisory Board: Jazz Pharmaceuticals, Inc. Consultant: Apinmed, Inc. and Jazz Pharmaceuticals, Inc. Research Support: Apnimed, Inc; Avadel; Inspire Medical Systems; Jazz Pharmaceuticals, Inc.; and Suven Life Sciences

Marlon (Tony) Graham, MD (peer reviewer)

Kashemi D. Rorie, PhD (planning committee)

Evan Luberger (planning committee)

Susan H. Yarbrough, CHCP (planning committee)

Sharon Tordoff (planning committee)

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Additional Formats

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit our Privacy & Confidentiality page.

Questions about this activity?

Call us at (877) CME-PROS or (877) 263-7767

 

NOTE: Pharmacist CE Universal Activity Number, Enduring: JA0007185-0000-22-062-H01-P.

 

BC-063-050922-43

Related Activities

Sleep Disorders
01/18/2023

A New Dawn in the Management of Idiopathic Hypersomnia: An Adaptive Learning Approach to Diagnosis and Implementing Clinical Trial Updates

1.00 Hour
Begin Learn More
Sleep Disorders
05/09/2022

Navigating the Neurophysiology of Sleep and Cataplexy: The Significance of Select Neurotransmitters

1.00 Hours
Begin Learn More
Sleep Disorders
06/16/2020

Laying to Rest Challenges in Managing Excessive Daytime Sleepiness in Patients with Obstructive Sleep Apnea or Narcolepsy – An Augmented Reality Experience

0.00 Expired
Begin Learn More
Crafting an Individualized Plan to Optimize Patient Outcomes: Safe, Effective, and Personalized Treatment
Event Date: 05/09/2022
Begin